Two weeks of daily injections and continuous infusion of recombinant human growth hormone (GH) in GH-deficient adults: I. Effects on insulin-like growth factor-I (IGF-I), GH and IGF binding proteins, and glucose homeostasis

Metabolism: Clinical and Experimental

Volumn 45, Issue 3, 1996, Pages 362-369

  Johansson, Jan Ove ^a,b   Oscarsson, Jan ^a   Bjarnason, Ragnar ^a   Bengtsson, Bengt Åke ^a  

^a UNIVERSITY OF GOTHENBURG   (Sweden)

^b SAHLGRENSKA UNIVERSITY HOSPITAL   (Sweden)

Author keywords

[No Author keywords available]

Indexed keywords

GROWTH HORMONE BINDING PROTEIN; HUMAN GROWTH HORMONE; LIOTHYRONINE; RECOMBINANT GROWTH HORMONE; SOMATOMEDIN BINDING PROTEIN 1; SOMATOMEDIN BINDING PROTEIN 3; SOMATOMEDIN C; THYROTROPIN; THYROXINE;

ADULT; ARTICLE; CHROMOPHOBE ADENOMA; CLINICAL ARTICLE; CLINICAL TRIAL; CONTINUOUS INFUSION; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; FATTY ACID BLOOD LEVEL; GLUCOSE HOMEOSTASIS; GROWTH HORMONE BLOOD LEVEL; GROWTH HORMONE DEFICIENCY; HORMONE SUBSTITUTION; HUMAN; LIOTHYRONINE BLOOD LEVEL; MALE; ORAL GLUCOSE TOLERANCE TEST; PRIORITY JOURNAL; SUBCUTANEOUS DRUG ADMINISTRATION; THYROTROPIN BLOOD LEVEL; TREATMENT OUTCOME;

EID: 0030007487     PISSN: 00260495     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0026-0495(96)90292-9     Document Type: Article

References (50)

1. Stolar MW, Baumann G: Secretory patterns of growth hormone during basal periods in man. Metabolism 35:883-888, 1986
2. Winer LM, Shaw MA, Baumann G: Basal plasma growth hormone levels in man: New evidence for rhythmicity of growth hormone secretion. J Clin Endocrinol Metab 70:1678-1686, 1990
3. Eriksson L, Frankenne F, Edén S, et al: Growth hormone 24-h serum profiles during pregnancy - Lack of pulsatility for the secretion of the placental variant. Br J Obstet Gynaecol 96:949-953, 1989
4. Hartman ML, Veldhuis JD, Johnson ML, et al: Augmented growth hormone (GH) secretory burst frequency and amplitude mediate enhanced GH secretion during a two-day fast in normal men. J Clin Endocrinol Metab 74:757-765, 1992
5. Asplin CM, Faria ACS, Carlsen EC, et al: Alterations in the pulsatile mode of growth hormone release in men and women with insulin-dependent diabetes mellitus. J Clin Endocrinol Metab 69:239-245, 1989
6. Jansson J-O, Albertsson-Wikland K, Edén S, et al: Effect of frequency of growth hormone administration on longitudinal bone growth and body weight in hypophysectomized rats. Acta Physiol Scand 114:261-265, 1982
7. Clark RG, Jansson J-O, Isaksson O, et al: Intravenous growth hormone: Growth responses to patterned infusions in hypophysectomized rats. J Endocrinol 104:53-61, 1985
8. Maiter D, Underwood LE, Maes M, et al: Different effects of intermittent and continuous growth hormone (GH) administration on serum somatomedin-C/insulin-like growth factor I and liver GH receptors in hypophysectomized rats. Endocrinology 123:1053-1059, 1988
9. Isgaard J, Carlsson L, Isaksson OGP, et al: Pulsatile intravenous growth hormone (GH) infusion to hypophysectomized rats increases insulin-like growth factor I messenger ribonucleic acid in skeletal tissues more effectively than continuous GH infusion. Endocrinology 123:2605-2610, 1988
10. Maiter D, Walker JL, Adam E, et al: Differential regulation by growth hormone (GH) of insulin-like growth factor I and GH receptor/binding protein gene expression in rat liver. Endocrinology 130:3257-3264, 1992
11. Mode A, Norstedt G, Simic B, et al: Continuous infusion of growth hormone feminizes hepatic steroid metabolism in the rat. Endocrinology 108:2103-2108, 1981
12. Edén S, Jansson J-O, Oscarsson J: Sexual dimorphism of growth hormone secretion, in Isaksson O, Binder C, Hall K, et al: (eds): Growth Hormone - Basic and Clinical Aspects. Amsterdam, The Netherlands, Elsevier Science, 1987, pp 129-153
13. Kastrup KW, Christiansen JS, Andersen JK, et al: Increased growth rate following transfer to daily sc administration from three weekly im injections of hGH in growth hormone deficient children. Acta Endocrinol (Copenh) 104:148-152, 1983
14. Jørgensen JOL, Møller N, Lauritzen T, et al: Pulsatile versus continuous intravenous administration of growth hormone (GH) in GH-deficient patients: Effects on circulating insulin-like growth factor-I and metabolic indices. J Clin Endocrinol Metab 70:1616-1623, 1990
15. Laursen T, Jørgensen JOL, Christiansen JS: Metabolic response to growth hormone (GH) administered in a pulsatile, continuous or combined pattern. Endocrinol Metab 1:33-40, 1994
16. Hoffman DM, O'Sullivan AJ, Baxter RC, et al: Diagnosis of growth-hormone deficiency in adults. Lancet 343:1064-1068, 1994
17. Carlsson LMS, Rowland AM, Clark RG, et al: Ligand-mediated immunofunctional assay for quantitation of growth hormone-binding protein in human blood. J Clin Endocrinol Metab 73:1216-1223, 1991
18. Brummer R-JM, Rosén T, Bengtsson B-Å: Evaluation of different methods of determining body composition, with special reference to growth hormone-related disorders. Acta Endocrinol (Copenh) 128:30-36, 1993 (suppl 2)
19. Jørgensen JOL, Flyvbjerg A, Lauritzen T, et al: Dose-response studies with biosynthetic human growth hormone (GH) in GH-deficient patients. J Clin Endocrinol Metab 67:36-40, 1988
20. Johannsson G, Oscarsson J, Johansson J-O, et al: Variation over 24 hours in serum insulin-like growth factor I during growth hormone treatment of adults with growth hormone deficiency. Endocrinol Metab 2:156,1995 (suppl B, abstr)
21. Jørgensen JOL, Blum WF, Møller N, et al: Short-term changes in serum insulin-like growth factors (IGF) and IGF binding protein 3 after different modes of intravenous growth hormone (GH) exposure in GH-deficient patients. J Clin Endocrinol Metab 72:582-587, 1991
22. Suikkari A-M, Koivisto VA, Rutanen E-M, et al: Insulin regulates the serum levels of low molecular weight insulin-like growth factor-binding protein. J Clin Endocrinol Metab 66:266-272, 1988
23. Cotterill AM, Cowell CT, Baxter RC, et al: Regulation of the growth hormone-independent growth factor-binding protein in children. J Clin Endocrinol Metab 67:882-887, 1988
24. Hall K, Lundin G, Póvoa G: Serum levels of the low molecular weight form of insulin-like growth factor binding protein in healthy subjects and patients with growth hormone deficiency, acromegaly and anorexia nervosa. Acta Endocrinol (Copenh) 118:321-326, 1988
25. Valk NK, vd Lely AJ, de Herder WW, et al: The effects of human growth hormone (GH) administration in GH-deficient adults: A 20-day metabolic ward study. J Clin Endocrinol Metab 79:1070-1076, 1994
26. Bjarnason R, Albertsson-Wikland K, Carlsson LMS: Acute and chronic effects of subcutaneous growth hormone (GH) injections on plasma levels of GH binding protein in short children. J Clin Endocrinol Metab 80:2756-2760, 1995
27. Tauber M, De Bouet Du Portal H, Sallerin-Caute B, et al: Differential regulation of serum growth hormone (GH)-binding protein during continuous infusion versus daily injection of recombinant human GH in GH-deficient children. J Clin Endocrinol Metab 76:1135-1139, 1993
28. Ho KKY, Jørgensen JOL, Valiontis E, et al: Different modes of growth hormone (GH) administration do not change GH binding protein activity in man. Clin Endocrinol (Oxf) 38:143-148, 1993
29. Bick T, Hochberg Z, Amit T, et al: Roles of pulsatility and continuity of growth hormone (GH) administration in the regulation of hepatic GH-receptors, and circulating GH-binding protein and insulin-like growth factor-I. Endocrinology 131:423-429, 1992
30. Salomon F, Cuneo RC, Hesp R, et al: The effects of treatment with recombinant human growth hormone on body composition and metabolism in adults with growth hormone deficiency. N Engl J Med 321:1797-1803, 1989
31. Fowelin J, Attvall S, Lager I, et al: Effects of treatment with recombinant human growth hormone on insulin sensitivity and glucose metabolism in adults with growth hormone deficiency. Metabolism 42:1443-1447, 1993
32. Jørgensen JOL, Møller N, Lauritzen T, et al: Evening versus morning injections of growth hormone (GH) in GH-deficient patients: Effects on 24-hour patterns of circulating hormones and metabolites. J Clin Endocrinol Metab 70:207-214, 1990
33. Yalow RS, Goldsmith SJ, Berson SA: Influence of physiologic fluctuations in plasma growth hormone on glucose tolerance. Diabetes 18:402-408, 1969
34. Fowelin J, Attvall S, von Schenck H, et al: Characterization of the insulin-antagonistic effect of growth hormone in man. Diabetologia 34:500-506, 1991
35. Boyle PJ, Avogaro A, Smith L, et al: Absence of the dawn phenomenon and abnormal lipolysis in type 1 (insulin-dependent) diabetic patients with chronic growth hormone deficiency. Diabetologia 35:372-379, 1992
36. Tamborlane WV, Genel M, Gianfredi S, et al: The effect of small but sustained elevations in circulating growth hormone on fuel metabolism in growth hormone deficiency. Pediatr Res 18:212-215, 1984
37. Boulware SD, Tamborlane WV, Matthews LS, et al: Diverse effects of insulin-like growth factor I on glucose, lipid, and amino acid metabolism. Am J Physiol 262:E130-E133, 1992
38. Turkalj I, Keller U, Ninnis R, et al: Effect of increasing doses of recombinant human insulin-like growth factor-I on glucose, lipid, and leucine metabolism in man. J Clin Endocrinol Metab 75:1186-1191, 1992
39. Mauras N, Horber FF, Haymond MW: Low dose recombinant human insulin-like growth factor-I fails to affect protein anabolism but inhibits islet cell secretion in humans. J Clin Endocrinol Metab 75:1192-1197, 1992
40. Guler H-P, Zapf J, Froesch ER: Short-term metabolic effects of recombinant human insulin-like growth factor I in healthy adults. N Engl J Med 317:137-140, 1987
41. Davidson MB: Effect of growth hormone on carbohydrate and lipid metabolism. Endocr Rev 8:115-131, 1987
42. . Raben MS, Hollenberg CH: Effect of growth hormone on plasma fatty acids. J Clin Invest 38:484-488, 1959
43. Møller J, Jørgensen JOL, Laursen T, et al: Growth hormone dose regimens in adult GH deficiency: Effects on biochemical growth markers and metabolic parameters. Clin Endocrinol (Oxf) 39:403-408, 1993
44. Møller N, Schmitz O, Pørksen N, et al: Dose-response studies on the metabolic effects of a growth hormone pulse in humans. Metabolism 41:172-175, 1992
45. Randle PJ, Garland PB, Hales CN, et al: The glucose fatty-acid cycle: Its role in insulin sensitivity and the metabolic disturbances of diabetes mellitus. Lancet 1:785-789, 1963
46. Thiébaud D, DeFronzo RA, Jacot E, et al: Effect of long chain triglyceride infusion on glucose metabolism in man. Metabolism 31:1128-1136, 1982
47. Clore JN, Glickman PS, Nestler JE, et al: In vivo evidence for hepatic autoregulation during FFA-stimulated gluconeogenesis in normal humans. Am J Physiol 261:E425-E429, 1991
48. Fanelli C, Calderone S, Epifano L, et al: Demonstration of a critical role for free fatty acids in mediating counterregulatory stimulation of gluconeogenesis and suppression of glucose utilization in humans. J Clin Invest 92:1617-1622, 1993
49. Jørgensen JOL, Møller J, Laursen T, et al: Growth hormone administration stimulates energy expenditure and extrathyroidal conversion of thyroxine to triiodothyronine in a dose-dependent manner and suppresses circadian thyrotropin levels: Studies in GH-deficient adults. Clin Endocrinol (Oxf) 41:609-614, 1994
50. Bengtsson B-Å, Edén S, Lönn L, et al: Treatment of adults with growth hormone (GH) deficiency with recombinant human GH. J Clin Endocrinol Metab 76:309-317, 1993